Added to YB: 2025-09-23
Pitch date: 2025-09-19
HVO.L [neutral]
hVIVO plc
-32.65%
current return
Author Info
Increasing Odds shares their investment journey in their newsletter. Sign up for the newsletter.
Company Info
hVIVO plc operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America.
Market Cap
GBP 67.2M
Pitch Price
GBP 0.10
Price Target
N/A
Dividend
2.02%
EV/EBITDA
2.20
P/E
6.37
EV/Sales
0.54
Sector
Life Sciences Tools and Services
Category
N/A
Exploring AIM: A-Z Part 16 - hVIVO plc
HVO.L pass: £67M contract clinical development provider serving 7/10 largest biopharma cos. H1 revenue -33%, EBITDA margin halved to 12%, FY margin turning negative. Order book fell £71M to £40M. Did £10.5M acquisitions. 2023: £16.4M EBITDA, 1.69p EPS vs 9.7p price. Covid beneficiary now hit by tight R&D spending.
Read full article (1 min)